URGN

UroGen Pharma Ltd.$39.36+0.20 (+0.51%)

Prev Close$39.19·MCap$1.91B·P/E—·Vol681.2K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$160.6K

◆

Net Activity

Net Seller

$160.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at UroGen Pharma Ltd. (URGN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $160.6K. The most recent insider transaction was by Schoenberg Mark (Chief Medical Officer), who sold $16.6K worth of shares on Sep 7, 2025. UroGen Pharma Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.91B.

URGN Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 7, 2025	Schoenberg Mark	Chief Medical Officer	Sell	871	$19.11	$16.6K	0
Jul 28, 2025	Smith Jason Drew	General Counsel	Sell	7,522	$19.14	$144.0K	0
Jun 8, 2025	Schoenberg Mark	Chief Medical Officer	Sell	5,162	$7.37	$38.0K	0
May 18, 2021	Henderson Molly	Chief Financial Officer	Buy	2,500	$15.85	$39.6K	2,500
May 18, 2021	Smith Jason Drew	General Counsel	Buy	2,500	$15.71	$39.3K	2,500

URGN Insider Buying Activity

The following table shows recent insider purchases of UroGen Pharma Ltd. (URGN) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 18, 2021	Henderson Molly	Chief Financial Officer	Buy	2,500	$15.85	$39.6K	2,500
May 18, 2021	Smith Jason Drew	General Counsel	Buy	2,500	$15.71	$39.3K	2,500

URGN Insider Selling Activity

The following table shows recent insider sales of UroGen Pharma Ltd. (URGN) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Sep 7, 2025	Schoenberg Mark	Chief Medical Officer	Sell	871	$19.11	$16.6K
Jul 28, 2025	Smith Jason Drew	General Counsel	Sell	7,522	$19.14	$144.0K
Jun 8, 2025	Schoenberg Mark	Chief Medical Officer	Sell	5,162	$7.37	$38.0K